These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34721981)

  • 41. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
    Fliser D; Kollerits B; Neyer U; Ankerst DP; Lhotta K; Lingenhel A; Ritz E; Kronenberg F; ; Kuen E; König P; Kraatz G; Mann JF; Müller GA; Köhler H; Riegler P
    J Am Soc Nephrol; 2007 Sep; 18(9):2600-8. PubMed ID: 17656479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model.
    Sugiura H; Matsushita A; Futaya M; Teraoka A; Akiyama KI; Usui N; Nagano N; Nitta K; Tsuchiya K
    PLoS One; 2018; 13(3):e0191706. PubMed ID: 29518087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of Fgf23 and Balp with Bone Mineral Density in Hemodialysis Patients.
    Bouksila M; Mrad M; Kaabachi W; Kalai E; Smaoui W; Rekik S; Krir A; Issaoui N; Hamzaoui K; Sahli H; Kateb ECE; Zouaghi MK; Bahlous A
    J Med Biochem; 2019 Oct; 38(4):418-426. PubMed ID: 31496905
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients.
    Gonzalez-Parra E; Gonzalez-Casaus ML; Galán A; Martinez-Calero A; Navas V; Rodriguez M; Ortiz A
    Nephrol Dial Transplant; 2011 Aug; 26(8):2567-71. PubMed ID: 21436379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Abnormalities in renal tubular phosphate handling in children with sickle cell disease.
    Raj VM; Freundlich M; Hamideh D; Alvarez O; Seeherunvong W; Abitbol C; Katsoufis C; Chandar J; Ruiz P; Zilleruelo G
    Pediatr Blood Cancer; 2014 Dec; 61(12):2267-70. PubMed ID: 25132581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of fibroblast growth factor-23 in cardiorenal syndrome.
    Kovesdy CP; Quarles LD
    Nephron Clin Pract; 2013; 123(3-4):194-201. PubMed ID: 23942553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.
    Lavi-Moshayoff V; Wasserman G; Meir T; Silver J; Naveh-Many T
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F882-9. PubMed ID: 20685823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of fibroblast growth factor 23 production in bone in uremic rats.
    Saji F; Shiizaki K; Shimada S; Okada T; Kunimoto K; Sakaguchi T; Hatamura I; Shigematsu T
    Nephron Physiol; 2009; 111(4):p59-66. PubMed ID: 19339809
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Associations of fibroblast growth factor 23 with urate metabolism in patients with chronic kidney disease.
    Sakoh T; Nakayama M; Tsuchihashi T; Yoshitomi R; Tanaka S; Katafuchi E; Fukui A; Shikuwa Y; Anzai N; Kitazono T; Tsuruya K
    Metabolism; 2016 Oct; 65(10):1498-507. PubMed ID: 27621185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neutrophil Gelatinase-Associated Lipocalin, Fibroblast Growth Factor 23, and Soluble Klotho in Long-Term Kidney Donors.
    Thorsen IS; Bleskestad IH; Jonsson G; Skadberg Ø; Gøransson LG
    Nephron Extra; 2016; 6(3):31-39. PubMed ID: 27920796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD.
    Krishnasamy R; Tan SJ; Hawley CM; Johnson DW; Stanton T; Lee K; Mudge DW; Campbell S; Elder GJ; Toussaint ND; Isbel NM
    BMC Nephrol; 2017 Sep; 18(1):281. PubMed ID: 28870151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of ferric citrate hydrate on FGF23 and PTH levels in patients with non-dialysis-dependent chronic kidney disease with normophosphatemia and iron deficiency.
    Iguchi A; Yamamoto S; Yamazaki M; Tasaki K; Suzuki Y; Kazama JJ; Narita I
    Clin Exp Nephrol; 2018 Aug; 22(4):789-796. PubMed ID: 29181658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between GFR, intact PTH, oxidized PTH, non-oxidized PTH as well as FGF23 in patients with CKD.
    Zeng S; Querfeld U; Feger M; Haffner D; Hasan AA; Chu C; Slowinski T; Bernd Dschietzig T; Schäfer F; Xiong Y; Zhang B; Rausch S; Horvathova K; Lang F; Karl Krämer B; Föller M; Hocher B
    FASEB J; 2020 Nov; 34(11):15269-15281. PubMed ID: 32964520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.
    Leifheit-Nestler M; Große Siemer R; Flasbart K; Richter B; Kirchhoff F; Ziegler WH; Klintschar M; Becker JU; Erbersdobler A; Aufricht C; Seeman T; Fischer DC; Faul C; Haffner D
    Nephrol Dial Transplant; 2016 Jul; 31(7):1088-99. PubMed ID: 26681731
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum Levels of Fibroblast Growth Factor 23 in People Living with HIV.
    Yoshino Y; Seo K; Kitazawa T; Ota Y
    Curr HIV Res; 2019; 17(3):198-203. PubMed ID: 31490759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum phosphate and phosphate-regulatory hormones in COPD patients.
    Stroda A; Brandenburg V; Daher A; Cornelissen C; Goettsch C; Keszei A; Dreher M
    Respir Res; 2018 Sep; 19(1):183. PubMed ID: 30236113
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The fibroblast growth factor receptor mediates the increased FGF23 expression in acute and chronic uremia.
    Hassan A; Durlacher K; Silver J; Naveh-Many T; Levi R
    Am J Physiol Renal Physiol; 2016 Feb; 310(3):F217-21. PubMed ID: 26311115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.